Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — Q2 2026 Earnings Presentation
38 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, Jul 28, 2026
Slide 1: Q2 2026 Investor Presentation
Q2 2026 Investor Presentation As of 28 July 2026
Slide 2: Presenting Team
Presenting Team Ibrahim Al Khudair Faisal Al Nassar Esam Al Mashloum Investor Relations Manager Chief Executive Officer Vice President, Finance Q2 2026 HMG Investor Presentation
Slide 3: Agenda
Agenda 1 Financial Performance 2 Projects Update 3 Q&A Key Financial Highlights 5 12 Q&A 13 Projects Update – Completed & Balance Sheet Highlights 7 Future Projects Financial Performance Indictors 8 Leverage Levels 9 Declared Cash Dividends 10 Appendices Appendix #1 Appendix #2 Appendix #3 4 Operati
Slide 4: Financial Performance
1 Financial Performance
Slide 5: Key Financial Highlights: Q2 2026
Key Financial Highlights: Q2 2026 HMG Revenue ▲+622▲+18.4% 3,384 4,006 Gross Profit 14.6% Gross Profit Margin % SEGMENTAL REVENUE Q2 2026 1,222 Q2 2026 30.5% Q2 2025 1,066 Q2 2025 31.5% Q2-25 VS Q2-26 HOSPITALS / 2,645 78.2% HEALTHCARE 77.3% 3,096 FACILITIES EBITDA 21.4% EBITDA Margin % +451 +17. 1%
Slide 6: Key Financial Highlights: H1 2026
Key Financial Highlights: H1 2026 HMG Revenue ▲+900▲+13.8% 6,542 7,442 Gross Profit 4.0% Gross Profit Margin % SEGMENTAL REVENUE H1 2026 2,178 H1 2026 29.3% H1 2025 2,094 H1 2025 32.0% H1-25 VS H1-26 HOSPITALS / HEALTHCARE 76.9% 13.2% 5,078 77.6% FACILITIES 5,720 EBITDA EBITDA Margin % +642 +12.6% H
Slide 7: Balance Sheet Highlights: H1 2026
Balance Sheet Highlights : H1 2026 8.2% Billion 9.4% 7.8% 9.7% Account Receivable Cash and bank Account Receivable Cash and bank 1.94 1.83 2.32 2.18 5.0% 5.0% Inventories 35.8% Inventories 35.4% Equity 1.23 Equity 1.12 8.84 7.96 2.9% H1-25 2.6% Other Current H1-25 H1-26 Other Current Total Assets To
Slide 8: Financial Performance Indicators: H1 2026
Financial Performance Indicators: H1 2026 Profitability eased from a strong base, while liquidity and the working-capital cycle stayed broadly healthy. ROE ROA ROCE Current Ratio 29.60% 9.89% 14.77% 1.12x 32.13% 11.53% 16.24% 1.18x Receivables (Days) Payables (Days) Inventory (Days) Cash Cycle (Days
Slide 9: Leverage Levels: H1 2026
Leverage Levels : H1 2026 Total Liabilities and Equity million Liabilities/Total Assets Liabilities/Equity H1 2026 0.64x H1 2026 1.79x H1 2025 0.65x H1 2025 1.82x 7,967 35.44% 35.81% 8,841 Debt / Equity Net Debt / EBITDA H1 2026 1.10x H1 2026 1.95x H1 2025 1.14x H1 2025 2.06x 14,517 64.56% 64.19% 15
Slide 10: Declared Cash Dividends
Declared Cash Dividends Declared Dividends Pay-out 1.33 per share 70.25% Declared Cash Dividends – Q2 2026 2026 465.5 mn 70.24% 1.01 per share 353.5 mn Current Capital 3.5 billion 1.31 per share 458.50 mn 70.41% Number of Shares 350 million 423.50 mn 70.32% 1.21 per share Dividend to be Distributed
Slide 11: Projects Update
2 Projects Update
Slide 12: Projects Update – Completed & Future Projects
Projects Update – Completed & Future Projects Solidifying our market leadership through robust expansion plans and progressing our projects Completed Projects Future Projects Al Fayhaa Hospital Women’s Health Hospital Sehat Al Kharj Hospital Red Sea Hospital Tabuk Hospital Munsiyah Hospital Jeddah R
Slide 13: Q&A
3 Q&A OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE
Slide 14: Operational Highlights
4 Appendix #1 Operational Highlights
Slide 15: Q2 2026 Key Highlights
Q2 2026 Key Highlights Key Highlights ESG highlights Opened a new medical center in Al Rabwah District, Riyadh Established a strategic partnership with a leading charitable organization in Qassim to provide breast cancer screening Launched the Kingdom’s first organ donation center within the and onc
Slide 16: Q2 2026 Key Highlights
Q2 2026 Key Highlights Major CME Activities Recognitions Healthcare Systems 5th Innovation Hackathon International Conference 2026 Concluded at HMG on Diabetes and hospital. Endocrinology 20th Annual Conference of Hosted Kidney Transplant the Saudi Society of Seminar Under the Theme Neurosurgery “Wh
Slide 17: Q2 2026 Key Highlights
Q2 2026 Key Highlights Medical Excellence Continuous Medical Research Center Postgraduate Program Education 1 Journal issued 145 Activities 210+ Hours 63 30 Research paper published Residency & Fellowship program 45+ Research proposals submitted to 280+ Speakers 5,700+ Participants accredited by Sau
Slide 18: Q2 2026 Key Highlights
Q2 2026 Key Highlights HMG App Highlight Interaction Booked Appointments +338.7m +2.2m interactions appointments Habib Live Care Home Healthcare +163.3k +11.1k transactions transactions Q2 2026 HMG Investor Presentation 18
Slide 19: Our People
Our People We continue to attract and retain top talent Physician Qualifications 25.4k+ 59% female staff Payroll staff 41% male staff 45% 6,200+ 90%+ Physicians Retention Rate 28% 90+ 41% Nationalities Saudi national staff 27% Training via Virtual Academy Platform Saudi Western (Including North Amer
Slide 20: Investment Case
Investment Case Attractive Industry Fundamentals HMG is committed to patient safety and wellbeing, providing patients with the highest standards of Adaptable Operating Model medical technology, exceptional patient experiences and sustainability to consistently deliver best-in-class care through its
Slide 21: Summarized Financials
5 Appendix #2 Summarized Financials
Slide 22: Financial Review
Financial Review Key Financial Information and KPIs H1 2026 H1 2025 Statement of Income million Revenue 7,442 6,542 Gross profit 2,178 2,094 Operating income 1,358 1,271 Profit attributable to equity holders of the parent 1,166 1,148 Balance Sheet million Current assets 6,199 5,728 Non-current asset
Slide 23: Financial Review (Continued)
Financial Review (Continued) Key Financial Information and KPIs H1 2026 H1 2025 Cash Flows million Net cash from operating activities 1,832 1,196 Net cash used in investing activities (1,103) (1,684) Net cash used in financing activities (689) (218) Cash and Cash Equivalents, Beginning of the Period
Slide 24: About HMG
6 Appendix #3 About HMG
Slide 25: About HMG
Care for About HMG Patients and Communities Intelligent at Exceptional the Core Talent Our Values Our values define who we are, providing a clear sense of purpose and the motivation to deliver exceptional outcomes for all our stakeholders. They Think Big and Act Fast Accountability guide our strateg
Slide 26: About HMG (continued)
About HMG (continued) HMG Universe Medical Diagnostic Laboratories (MD Labs) provide HMG Hospitals deliver comprehensive secondary specialized testing services that deliver high-quality and tertiary healthcare services, offering an results with exceptional speed. MD Labs adopted extensive range of s
Slide 27: Key Message
Key Message Strategic pillars underpin our drive to deliver best-in-class healthcare services Catalysts for value Best-in-class Efficiency drivers creation • Technology: Pioneer in healthcare • Efficient cash conversion cycle: • Regional integrated healthcare technology, award-winning hospital short
Slide 28: Geographic Footprint
Geographic Footprint 25+ 6,200+ 50 60+ Medical Physicians Pharmacies Sub- Facilities specialties 1. Sahafa (Riyadh) 8. Fayhaa (Jeddah) 2. Olaya (Riyadh) 9. Muhammadiyah (Jeddah) 3. Takhassusi (Riyadh) 10. Qassim 4. Rayan (Riyadh) 11. Khobar 5. Suwaidi (Riyadh) 12. Kharj 6. Women’s Health (Riyadh) 13
Slide 29: Geographic Footprint (continued)
Geographic Footprint (continued) Our vast footprint across Riyadh MAP KEY Hospitals Medical Centers Hospitals Head Office Under Construction Urgent HMG Academy and Care Collage for Knowledge Pharmacy Q2 2026 HMG Investor Presentation 29
Slide 30: Strategy
Strategy OUR PILLARS Drivers Outcomes Our Growth Strategy Strengthening • Rigorous quality and safety standards • Patient and customer-centric Built around clarity of purpose and disciplined execution, our • Top-notch empowered employees value service delivery the Core corporate strategy is designed
Slide 31: Business Model
Business Model OUR KEY STRENGTHS WHAT WE DO HMG is uniquely positioned as the leading • Forefront Of Technology and Innovation • Modern Facilities and Comprehensive Services private healthcare group in the region, with the expertise, experience and culture • Trusted Brand in Prime Locations • Sustai
Slide 32: Medical Operation Strategic Pillars
Medical Operation Strategic Pillars Our Fundamental Strategic Pillars Patient Safety Patient Experience Performance and Since its foundation, transformation and evolution, HMG has Enhancing the safety of our Enhancing patient experience by Efficiency always abided by five key strategic pillars that
Slide 33: Pioneer In Healthcare Technology
Pioneer In Healthcare Technology Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine Developing cutting edge technology HIS (VIDA) 81 Vida implemented sites Pioneer in healthcare technology, award-winning ▪ Tele-Cardiology (Nabad 24 program): Des
Slide 34: Board of Directors
Board of Directors Non-executives Executives Independents Mr. Faisal Al Nassar Dr. Sulaiman Al Habib Mr. Obaid Al Rasheed Board member, Group CEO and Group Founder and Chairman CFO Vice Chairman Dr. Abdulrahman Al Turaigi Mr. Hesham Al Habib Board member Eng. Saleh Al Habib Board member and Chief Bo
Slide 35: Committee Members
Committee Members Audit Nomination and Remuneration Executive Dr. Abdulrahman Al Turaigi Mr. Obaid Al Rasheed Eng. Saleh Al Habib Chairman Chairman Chairman Mr. Turki Al Luhaid Eng. Saleh Al Habib Mr. Faisal Al Nassar Member Member Member Mr. Abdulaziz Al Haidari Mr. Rasheed Al Rasheed Mr. Hesham Al
Slide 36: Executive Management
Executive Management Highly experienced, high caliber management Mr. Faisal Al Nassar CEO & President CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Eng. Abdullah Dr. Riyad Al Atiqi Prof. Abdullah Al Herbish Mr. Hesham Al Habib Mr. Ahmed Babatin Al Sudais General Director Senior Vice Presi
Slide 37: Disclaimer
Disclaimer Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm
Slide 38: Thank You
Investor Relations Department Thank You King Fahad Road, Olaya District P.O. Box: 91877, Riyadh 11643, Kingdom of Saudi Arabia Phone: + 966 (11) 5259999, Ex. 4919 Fax: + 966 (11) 2174980 Email: investor.relations@drsulaimanalhabib.com OVERVIEW STRATEGIC REVIEW OPERATING REVIEW GOVERNANCE
Dr. Sulaiman Al Habib Medical Services Group (HMG) — Q2 2026 Earnings Presentation on 6ix